Ascentage Pharma Group International (FRA:36X)

FRA:36X Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,897	1,750	900	796	819	896
Market Cap Growth	30.82%	94.41%	13.02%	-2.79%	-8.59%	28.23%
Enterprise Value	1,905	1,831	913	777	702	855
Last Close Price	5.05	5.60	2.84	2.96	2.84	3.68
PS Ratio	40.86	13.48	31.78	27.99	212.05	574.86
PB Ratio	23.61	48.23	99.87	14.36	4.79	8.45
P/TBV Ratio	27.99	80.87	-	19.59	5.15	9.47
EV/Sales Ratio	40.98	14.11	32.24	27.31	181.70	548.17
Debt / Equity Ratio	2.54	6.09	25.42	4.39	0.88	0.63
Net Debt / Equity Ratio	0.08	1.47	9.84	0.71	-0.54	-0.59
Net Debt / EBITDA Ratio	-0.05	-1.34	-0.85	-0.34	0.73	0.75
Net Debt / FCF Ratio	-0.25	-2.96	-0.90	-0.34	0.64	0.58
Asset Turnover	0.13	0.38	0.08	0.07	0.01	0.01
Inventory Turnover	3.70	2.56	2.38	3.29	-	-
Quick Ratio	1.40	1.17	1.35	1.78	5.05	3.77
Current Ratio	1.54	1.26	1.44	1.86	5.22	3.91
Return on Equity (ROE)	-159.65%	-235.32%	-386.28%	-107.45%	-75.18%	-78.02%
Return on Assets (ROA)	-22.77%	-9.25%	-20.92%	-19.14%	-24.97%	-29.14%
Return on Capital Employed (ROCE)	-62.00%	-26.10%	-57.00%	-45.30%	-36.20%	-47.00%
Earnings Yield	-7.26%	-3.07%	-13.12%	-15.04%	-13.22%	-9.47%
FCF Yield	-1.36%	-1.03%	-10.95%	-14.60%	-17.57%	-12.02%
Buyback Yield / Dilution	-12.40%	-7.00%	-7.07%	-3.56%	-17.93%	-84.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.